A carregar...
Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy
Bone anabolic agents promoting bone formation and rebuilding damaged bones would ideally overcome the limitations of anti‐resorptive therapy, the current standard prescription for osteoporosis. However, the currently prescribed parathyroid hormone (PTH)‐based anabolic drugs present limitations and a...
Na minha lista:
| Publicado no: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4818757/ https://ncbi.nlm.nih.gov/pubmed/26941261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201505714 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|